Chronic prostatitis
Conditions
Interventions
Experimental group:Urinary Qingshu granules (20mg once, three times a day, taken with hot water)+Tamsulosin hydrochloride (0.2mg once a day) were treated for a total of 4 weeks.
Control group:Tamsulosin (0.2mg once a day), treated for a total of 4 weeks
Sponsors
The First Affiliated Hospital of Sun Yat sen University
Eligibility
Sex/Gender
Male
Age
18 Years to 50 Years
Inclusion criteria
Inclusion criteria: 1. Chronic prostatitis/chronic pelvic pain syndrome, with symptoms such as frequent urination, incomplete urination, and pain and discomfort in the perineum, testicles, and lumbosacral region (medical history>= 3 months). 2. Age is 18 years old or above (including 18 years old) and under 50 years old. 3. The subjects had a detailed understanding of the nature, significance, potential benefits, potential inconveniences, and risks of the trial before the trial, and voluntarily participated in this clinical trial. They were able to communicate well with the researchers, comply with the requirements of the entire study, and signed a written informed consent form.
Exclusion criteria
Exclusion criteria: 1. Used antibiotics or medications for treating prostatitis within the past week (including a- Receptor blocker, Chinese herbal medicine or traditional Chinese patent medicines and simple preparations); 2. Individuals with a specific history of allergies (asthma, urticaria, eczema, etc.), or individuals with allergic constitutions (such as those who are allergic to two or more drugs, food, pollen, or those known to be allergic to the components or analogues of this drug); 3. Individuals who have or are currently suffering from any clinically serious diseases, such as digestive, cardiovascular, endocrine, nervous or respiratory systems, hematological, immunological, psychiatric disorders, metabolic abnormalities, renal insufficiency, gastrointestinal dysfunction, or have a history of digestive tract diseases or surgeries that have affected the absorption of this drug, as determined by the researcher to have an impact on this study; 4. Patients who need to receive anesthetic drugs during administration, such as those undergoing painless gastrointestinal endoscopy; 5. Family planning during the study period or within 3 months after the end of the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| National Institutes of Health Chronic Prostatitis Symptom Index(NIH-CPSI); | — |
Secondary
| Measure | Time frame |
|---|---|
| Visual Analogue Scale(VAS);Quality of Life Inventory(QoL); | — |
Countries
China
Contacts
Public ContactSun Xiangzhou
The First Affiliated Hospital of Sun Yat sen University The First Affiliated Hospital of Sun Yat sen University
Outcome results
None listed